These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 3140772
1. Topical ciprofloxacin treatment of Pseudomonas keratitis in rabbits. O'Brien TP, Sawusch MR, Dick JD, Gottsch JD. Arch Ophthalmol; 1988 Oct; 106(10):1444-6. PubMed ID: 3140772 [Abstract] [Full Text] [Related]
2. Topical imipenem therapy of aminoglycoside-resistant Pseudomonas keratitis in rabbits. Sawusch MR, O'Brien TP, Valentine J, Dick JD, Gottsch JD. Am J Ophthalmol; 1988 Jul 15; 106(1):77-81. PubMed ID: 3164983 [Abstract] [Full Text] [Related]
3. The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis. Reidy JJ, Hobden JA, Hill JM, Forman K, O'Callaghan RJ. Cornea; 1991 Jan 15; 10(1):25-8. PubMed ID: 1902152 [Abstract] [Full Text] [Related]
4. Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis. Lauffenburger MD, Cohen KL. Cornea; 1993 Nov 15; 12(6):517-21. PubMed ID: 8261784 [Abstract] [Full Text] [Related]
5. Ciprofloxacin ointment versus ciprofloxacin drops for therapy of experimental Pseudomonas keratitis. Hobden JA, O'Callaghan RJ, Insler MS, Hill JM. Cornea; 1993 Mar 15; 12(2):138-41. PubMed ID: 8500320 [Abstract] [Full Text] [Related]
6. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis. Bu P, Riske PS, Zaya NE, Carey R, Bouchard CS. J Ocul Pharmacol Ther; 2007 Jun 15; 23(3):213-20. PubMed ID: 17593004 [Abstract] [Full Text] [Related]
7. Treatment of experimental bacterial keratitis with topical trovafloxacin. Barequet IS, Denton P, Osterhout GJ, Tuli S, O'Brien TP. Arch Ophthalmol; 2004 Jan 15; 122(1):65-9. PubMed ID: 14718297 [Abstract] [Full Text] [Related]
8. Ciprofloxacin iontophoresis for aminoglycoside-resistant pseudomonal keratitis. Hobden JA, Reidy JJ, O'Callaghan RJ, Insler MS, Hill JM. Invest Ophthalmol Vis Sci; 1990 Oct 15; 31(10):1940-4. PubMed ID: 2210988 [Abstract] [Full Text] [Related]
9. Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits. Aliprandis E, Ciralsky J, Lai H, Herling I, Katz HR. Cornea; 2005 Mar 15; 24(2):201-5. PubMed ID: 15725889 [Abstract] [Full Text] [Related]
10. Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis. Engel LS, Callegan MC, Hobden JA, Reidy JJ, Hill JM, O'Callaghan RJ. Curr Eye Res; 1995 Mar 15; 14(3):229-34. PubMed ID: 7796606 [Abstract] [Full Text] [Related]
11. The effect of topical ceftazidime on pseudomonas keratitis in rabbits. Kremer I, Robinson A, Braffman M, Drucker M, Goldenfeld M, Samra Z, Myszne-Daye N, Gaton D, Savir H. Cornea; 1994 Jul 15; 13(4):360-3. PubMed ID: 7924338 [Abstract] [Full Text] [Related]
12. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis. Guzek JP, Chacko D, Kettering JD, Wessels IF, Aprecio RM. Cornea; 1994 Nov 15; 13(6):500-4. PubMed ID: 7842708 [Abstract] [Full Text] [Related]
14. Effect of nitric oxide synthase inhibition in experimental Pseudomonas keratitis in rabbits. Er H, Turkoz Y, Ozerol IH, Uzmez E. Eur J Ophthalmol; 1998 Nov 15; 8(3):137-41. PubMed ID: 9793765 [Abstract] [Full Text] [Related]